Skip to main content
OpenTrials
Completed

NCT Number: NCT00997633

Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

SPECT was performed in 51 patients after cytoreductive surgery in combination with intraperitoneal chemotherapy. The detected volume was compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses that could be performed without further surgical intervention. SPECT data was found to predict feasibility of sequential postoperative intraperitoneal chemotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–74 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept of Surgical Sciences, Section of Surgery

S-751 85 Uppsala, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cytoreductive surgery and intraperitoneal chemotherapy
  • Single-Photon Emission Computed Tomography (SPECT) before the second course of treatment

Treatment and study plan

Primary outcomes

  1. Detected volume measured by SPECT compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses

Secondary outcomes

  1. The relationship between SPECT, feasibility of SPIC (intraperitoneal chemotherapy), and clinical variables

Sponsors and collaborators

Lead sponsor

Uppsala University

Other

Registry information

Official study title

Single-photon Emission Computed Tomography for Prediction of Treatment Results in Sequential Intraperitoneal Chemotherapy at Peritoneal Carcinomatosis

Important dates

Study start
1991
Primary completion
2004
Study completion
2004
First posted
Oct 19, 2009
Registry last updated
Oct 19, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.